Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Jan 22, 2020 10:59pm
151 Views
Post# 30586339

Something as changed at pli in past year they put

Something as changed at pli in past year they putThe company in financial position that would meet tsx criteria so they wiped out retail investors 
they had options to raise money they refused to consider 
they wrote down ivig 150 million they will benefit from taxe write down ,they didn’t have to do this since ivig was at advanced phase3 stage  doing this they could close the atm they approved just few months before up to 50 million  
they didn’t offer retail rights offering months before they took over the company that would have easily raised 100 million at much higher stock price less dilutive at a time investors still had confidence AS SOON. As they took over company then and only then they decided to offer this opportunity to retail investors and put a cap on it at 75 million to prevent retail investors from increasing their % of company 
then change the company ‘s name thinking people would forget what they did
then fire our chief scientist Lynne gagnon who with her team discovered prometic’s Molecules 
kory sorenson a ptevious board member quit just before they did takeover ask yourself why did she quit what will she say during questioning under oath 
YES THINGS HAVE CHANGED BUT NOTHING POSITIVE 
<< Previous
Bullboard Posts
Next >>